CervoMed to Participate in the Emerging Growth Conference 66

January 5, 2024

https://www.globenewswire.com/news-release/2024/01/05/2804604/0/en/CervoMed-to-Participate-in-the-Emerging-Growth-Conference-66.html

BOSTON, Jan. 05, 2024 (GLOBE NEWSWIRE) — CervoMed Inc. (NASDAQ:CRVO), a clinical stage company focused on developing treatments for degenerative diseases of the brain, today announced that Company’s Management will provide a corporate update at the Emerging Growth Conference 66, to be held virtually from January 10-11, 2024.

Read more at globenewswire.com

Related news for (CRVO)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.